Dr James Buteau is a nuclear medicine physician from Canada. He completed his medical degree at Université Laval (2012) and nuclear medicine specialisation at Université de Sherbrooke (2017). Following two years of practice as a consultant at Hôpital de la Cité-de-la-Santé, he undertook a fellowship in theranostics at Peter Mac. In 2020, he was awarded with the Detweiler Travelling Fellowship by the Royal College of Physicians and Surgeons of Canada.
James is a ProsTIC clinical and research fellow, as well as undertaking a PhD under the supervision of Prof Michael Hofman and A/Prof Arun Azad. He is focusing on imaging biomarkers, the role of PSMA PET/CT for prostate cancer diagnosis (PRIMARY2 trial, phase III) in collaboration with Prof Louise Emmett, and [161Tb]Tb-PSMA-I&T therapy for men with metastatic castration resistant prostate cancer (VIOLET trial, phase I/II).